Showing results (211-220 of 662) with videos related to
Sort By:
Pageof 67
Brain and Cognition|April 8, 2000
Impaired frontostriatal cognitive functioning following posteroventral pallidotomy in advanced Parkinson's diseaseG T Stebbins, J D Gabrieli, K M Shannon, et al.Clinical Neuropharmacology|December 1, 1987
Amantadine and motor fluctuations in chronic Parkinson's diseaseK M Shannon, C G Goetz, V S Carroll, et al.Neurology|December 31, 1997
Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating ScaleD A Bennett, K M Shannon, L A Beckett, et al.Clinical Neuropharmacology|April 6, 2001
Estrogen supplementation in the posthypoxic myoclonus rat modelK Kompoliti, C G Goetz, T Q Vu, et al.Clinical Neuropharmacology|October 28, 1998
Poor visual discrimination and visual hallucinations in Parkinson's diseaseN J Diederich, C G Goetz, R Raman, et al.European Journal of Pharmacology|January 21, 1986
The effect of antimuscarinic agents on haloperidol induced behavioral hypersensitivityP M Carvey, L C Kao, C M Tanner, et al.Circulation|February 8, 2006
Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implicationsJan Steffel, Thomas F Lüscher, Felix C TannerClinical Science (London, England : 1979)|October 23, 2009
Tissue factor: beyond coagulation in the cardiovascular systemAlexander Breitenstein, Giovanni G Camici, Felix C TannerAob PLANTS|December 22, 2012
Regression analysis of growth responses to water depth in three wetland plant speciesBrian K Sorrell, Chris C Tanner, Hans BrixCirculation Journal : Official Journal of the Japanese Circulation Society|December 10, 2009
Tissue factor and cardiovascular disease: quo vadis?Alexander Breitenstein, Felix C Tanner, Thomas F LüscherPageof 67